Delivery Order SPE2DB20D7066-SPE2DB26FC1NX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,744.56 to AmerisourceBergen Drug Corp for Drospirenone-EE 3-0.02 mg tablets (28-count), a hormonal contraceptive medication. The award, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this contract at its corporate office location....
- The Defense Logistics Agency awarded a delivery order valued at $6,785.38 to AmerisourceBergen Drug Corp for the supply of Drospirenone-EE 3-0.02 mg tablets in quantities of 28, with an ultimate completion date of September 10, 2025. This award represents a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and...
- The Defense Logistics Agency awarded a $2,816.89 delivery order to AmerisourceBergen Drug Corp for Drospirenone-EE 3-0.02 mg tablets (28-count packaging) on August 21, 2025, with completion scheduled for August 22, 2025. This contract represents a firm fixed-price, competitively awarded delivery order with no set-aside designation. The award was fulfilled by AmerisourceBergen Drug Corp's Corporate Office division, headquartered in Conshohocken, Pennsylvania, which serves as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Drospirenone-EE 3-0.02 mg tablets in a 28-count package. This is a firm fixed price, competitively awarded contract with a ceiling value of $1,140.05, with performance to be completed by December 9, 2025. The contract place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a $1,420.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Drospirenone-EE 3-0.02 mg tablets in quantities of 28 units. This non-set-aside contract is scheduled for completion by October 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement fulfilling immediate medical...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Drospirenone 4mg tablets in a 28-count package. This competitive, non-set-aside award carries a firm fixed price ceiling value of $7,458.51 and is scheduled for completion by September 24, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 24, 2025, for the supply of drospirenone-ethinyl estradiol 3-0.02 mg tablets in quantities of 28 units. The contract is a firm fixed-price delivery order with a ceiling value of $1,963.51, with an ultimate completion date of September 25, 2025. This award was not designated as a set-aside and was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $8,093.94 to AmerisourceBergen Drug Corp for the supply of Drospirenone 4mg 28-count units under contract 4568868132. This firm fixed price delivery order, awarded on July 23, 2025, represents a non-competitive set-aside contract with an ultimate completion date of August 19, 2025. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Drospirenone-EE 3-0.02 mg tablets in quantities of 28. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,566.38 and an ultimate completion date of October 13, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. Both entities are...
- This is a $1,353.40 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the provision of 4563561688 ! DROSPIRENONE-EE 3-0.02 MG TAB 28S, a pharmaceutical product. The delivery order is being issued under an Indefinite Delivery Contract (IDC) with Amerisourcebergen Drug Corp as the sole awardee, with a potential value of up to $999,999,999.00 and a performance period through...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB26FC1NXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,531.36 to AmerisourceBergen Drug Corp for Drospirenone-EE 3-0.02 mg tablets (28-count packages) on November 5, 2025, with completion targeted for November 6, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a pediatric contraceptive pharmaceutical product procured through competitive delivery order procedures to support federal medical supply requirements. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle extending through December 2026. As a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems, AmerisourceBergen Drug Corp maintains an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The parent indefinite delivery contract enables the company to fulfill diverse federal pharmaceutical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.5k | 11/5/25 |